Towards Healthcare
Point-of-Care Molecular Diagnostics Market to Expand USD 11.03 Bn by 2034

Point-of-Care Molecular Diagnostics Market 2025 Multiplex Testing & Portable Devices Driving 10.45% CAGR Growth

Based on market forecasts, the point-of-care molecular diagnostics sector will expand from USD 4.05 billion in 2024 to USD 11.03 billion by 2034, experiencing a CAGR of 10.45%. The point-of-care molecular diagnostics market is expanding due to increasing decentralized healthcare as well as growing advancements in multiplex tests. North America led the market due to the presence of the healthcare sector. 

  • Insight Code: 6041
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The point-of-care molecular diagnostics market stands at USD 4.48 billion in 2025 and is expected to reach USD 11.03 billion by 2034, growing at a CAGR of 10.45% from 2024 to 2034.

North America is currently leading the point-of-care molecular diagnostics market due to the presence of the healthcare sector.

Some key players include Abbott Laboratories, Roche Diagnostics, Danaher Corporation, and bioMerieux.

Key trends include growing funding for transforming rapid point-of-care diagnostics and acquisitions for enhancing the speed and affordability of POC molecular diagnostics.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.